pefloxacin has been researched along with Endocarditis, Bacterial in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (50.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carbon, C; Contrepois, A; Daldoss, C; Garaud, JJ; Kecir, M; Pangon, B; Sarrazin, C; Vallois, JM | 1 |
| Baron, D; Bugnon, D; Caillon, J; Drugeon, H; Jehl, F; Le Conte, P; Potel, G; Stephant, G; Xiong, YQ | 1 |
| Baron, D; Bugnon, D; Caillon, J; Conte, PL; Drugeon, HB; Potel, G; Xiong, YQ | 1 |
| Baron, DI; Bugnon, D; Caillon, J; Drugeon, HB; Juvin, ME; Le Conte, P; Potel, G; Xiong, YQ | 1 |
| Baron, D; Bugnon, D; Caillon, J; Drugeon, H; Gras, C; Jehl, F; Kergueris, MF; Le Conte, P; Navas, D; Potel, G; Xiong, YQ | 1 |
| Cacoub, P; Chapelon, C; Godeau, P; Thibon, M; Wechsler, B | 1 |
| Alessandri, N; Gentile, G; Martino, P; Micozzi, A; Santero, M; Venditti, M | 1 |
| Bauchet, J; Pangon, B; Regnier, B; Rouveix, E; Vachon, F; Wolff, M | 1 |
| Bayer, AS; Hirano, L; Yih, J | 1 |
| Bayer, AS; Greenberg, DP; Yih, J | 1 |
| Fillastre, JP; Humbert, G; Lemeland, JF; Thauvin, C | 1 |
| Chambers, HF; Hackbarth, CJ; Sande, MA; Scott, KG; Sullam, PM; Täuber, MG | 1 |
12 other study(ies) available for pefloxacin and Endocarditis, Bacterial
| Article | Year |
|---|---|
Pefloxacin in rabbits: protein binding, extravascular diffusion, urinary excretion and bactericidal effect in experimental endocarditis.
Topics: Animals; Anti-Infective Agents; Diffusion; Endocarditis, Bacterial; Escherichia coli Infections; Furosemide; Male; Nalidixic Acid; Pefloxacin; Protein Binding; Rabbits | 1984 |
Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa.
Topics: Animals; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Fosfomycin; Pefloxacin; Pseudomonas Infections; Rabbits | 1995 |
[Critical serum concentration of antibiotics. A therapeutic tool and means of comparative evaluation].
Topics: Animals; Ceftazidime; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Evaluation; Endocarditis, Bacterial; Infusions, Intravenous; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Serratia Infections; Serratia marcescens | 1995 |
In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis.
Topics: Animals; Ciprofloxacin; Colony Count, Microbial; Endocarditis, Bacterial; Female; Humans; Infusions, Intravenous; Pefloxacin; Rabbits; Serratia Infections; Serratia marcescens; Serum Bactericidal Test | 1994 |
Bactericidal effect of pefloxacin and fosfomycin against Pseudomonas aeruginosa in a rabbit endocarditis model with pharmacokinetics of pefloxacin in humans simulated in vivo.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Fosfomycin; Half-Life; Humans; Infusions, Intravenous; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Random Allocation; Treatment Outcome | 1997 |
Q-fever endocarditis and treatment with the fluoroquinolones.
Topics: Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Male; Pefloxacin; Q Fever; Rifampin | 1991 |
Successful treatment of Brucella melitensis endocarditis with pefloxacin.
Topics: Brucellosis; Endocarditis, Bacterial; Female; Humans; Middle Aged; Pefloxacin | 1990 |
[Treatment of septicemia and endocarditis with pefloxacine. 15 cases].
Topics: Adult; Aged; Anti-Infective Agents; Child; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Humans; Male; Middle Aged; Norfloxacin; Pefloxacin; Sepsis | 1986 |
Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 1988 |
Correlates of therapeutic efficacy in experimental methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Animals; Anti-Infective Agents; Endocarditis, Bacterial; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rabbits; Random Allocation; Staphylococcal Infections; Vancomycin | 1988 |
Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Infective Agents; Endocarditis, Bacterial; Fosfomycin; Male; Methicillin; Norfloxacin; Pefloxacin; Penicillin Resistance; Rats; Rats, Inbred Strains; Staphylococcal Infections | 1988 |
Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Endocarditis, Bacterial; Methicillin; Microbial Sensitivity Tests; Nalidixic Acid; Pefloxacin; Penicillin Resistance; Rabbits; Staphylococcal Infections; Vancomycin | 1985 |